43.100
+0,00%
2026-10-16
Fundamental Analysis
59 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +11.5% | +26.9% | 2 / 3 | +28.1% | -1.43 pp | -0.57 pp | +34.6% | 0.01 | 7.82 | 373 | +28,1% | 14,3 | +11,5% | 7.82 | 9.24 | −15,3% |
| Pts | 0 | 4 | 8 | 12 | 4 | 4 | 12 | 12 | 8 | |||||||
Valuation annotation:Price: 43.100 (close price on 2026-10-16)EPS (TTM): 5.509
Financial charts
1.Revenue & growth
VND bn373Q2/26
1.Revenue & growth
VND bn373Q2/26
2.Profit & growth
VND bn14,1Q2/26
3.Profit mix (Penman)
VND bn69,5Q2/26
4.Margins & cost structure
%7.4%Q2/26
5.Returns & cash cycle
% · days50.1%Q2/26
6.Earnings quality & cash
VND bn-35,0Q2/26
7.Asset structure
VND bn312Q2/26
8.Funding & debt health
VND bn · times312Q2/26
9.Revenue backlog
VND bn1,48Q2/26
10.Valuation
times · %7,8×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %1.409Q2/26
Adjusted EPS growth, latest quarter
10.5%
Average adjusted EPS growth, 3 quarters
26.6%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
-0.0%
Source: vnstockData through Q2/26